Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy

Sadia Zafar; Suvi Parviainen; Mikko Siurala; Otto Hemminki; Riikka Havunen; Siri Tahtinen; Simona Bramante; Lotta Vassilev; Hongjie Wang; Andre Lieber; Silvio Hemmi; Tanja de Gruijl; Anna Kanerva; Akseli  Hemminki

doi:10.1080/2162402X.2016.1265717

Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy

Sadia Zafar, Suvi Parviainen, Mikko Siurala, Otto Hemminki, Riikka Havunen, Siri Tahtinen, Simona Bramante, Lotta Vassilev, Hongjie Wang, Andre Lieber, Silvio Hemmi, Tanja de Gruijl, Anna Kanerva, Akseli Hemminki

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Artikkeli	1265717
Lehti	OncoImmunology
Vuosikerta	6
Numero	2
Sivumäärä	11
ISSN	2162-402X
DOI - pysyväislinkit	https://doi.org/10.1080/2162402X.2016.1265717
Tila	Julkaistu - 2017
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3111 Biolääketieteet
3122 Syöpätaudit

Pääsy asiakirjaan

10.1080/2162402X.2016.1265717

Siteeraa tätä

Zafar, S., Parviainen, S., Siurala, M., Hemminki, O., Havunen, R., Tahtinen, S., Bramante, S., Vassilev, L., Wang, H., Lieber, A., Hemmi, S., de Gruijl, T., Kanerva, A., & Hemminki, A. (2017). Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy. OncoImmunology, 6(2), [1265717]. https://doi.org/10.1080/2162402X.2016.1265717

Zafar, Sadia ; Parviainen, Suvi ; Siurala, Mikko ; Hemminki, Otto ; Havunen, Riikka ; Tahtinen, Siri ; Bramante, Simona ; Vassilev, Lotta ; Wang, Hongjie ; Lieber, Andre ; Hemmi, Silvio ; de Gruijl, Tanja ; Kanerva, Anna ; Hemminki, Akseli . / Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy. Julkaisussa: OncoImmunology. 2017 ; Vuosikerta 6, Nro 2.

@article{99dba1085c7044978667f718dab5f26a,

title = "Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy",

keywords = "CD40 ligand, dendritic cells, oncolytic adenovirus, T-cells, tumor microenvironment, PROTECTIVE ANTITUMOR IMMUNITY, VIVO GENE-TRANSFER, CANCER-PATIENTS, PROSTATE-CANCER, BREAST-CANCER, REPLICATING ADENOVIRUS, CARCINOMA-CELLS, SOLID TUMORS, T-CELLS, LIGAND, 3111 Biomedicine, 3122 Cancers",

author = "Sadia Zafar and Suvi Parviainen and Mikko Siurala and Otto Hemminki and Riikka Havunen and Siri Tahtinen and Simona Bramante and Lotta Vassilev and Hongjie Wang and Andre Lieber and Silvio Hemmi and {de Gruijl}, Tanja and Anna Kanerva and Akseli Hemminki",

year = "2017",

doi = "10.1080/2162402X.2016.1265717",

language = "English",

volume = "6",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "TAYLOR & FRANCIS INC",

number = "2",

}

Zafar, S, Parviainen, S, Siurala, M, Hemminki, O, Havunen, R, Tahtinen, S, Bramante, S, Vassilev, L, Wang, H, Lieber, A, Hemmi, S, de Gruijl, T, Kanerva, A & Hemminki, A 2017, 'Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy', OncoImmunology, Vuosikerta 6, Nro 2, 1265717. https://doi.org/10.1080/2162402X.2016.1265717

Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy. / Zafar, Sadia; Parviainen, Suvi; Siurala, Mikko; Hemminki, Otto; Havunen, Riikka; Tahtinen, Siri; Bramante, Simona; Vassilev, Lotta; Wang, Hongjie; Lieber, Andre; Hemmi, Silvio; de Gruijl, Tanja; Kanerva, Anna ; Hemminki, Akseli .

julkaisussa: OncoImmunology, Vuosikerta 6, Nro 2, 1265717, 2017.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy

AU - Zafar, Sadia

AU - Parviainen, Suvi

AU - Siurala, Mikko

AU - Hemminki, Otto

AU - Havunen, Riikka

AU - Tahtinen, Siri

AU - Bramante, Simona

AU - Vassilev, Lotta

AU - Wang, Hongjie

AU - Lieber, Andre

AU - Hemmi, Silvio

AU - de Gruijl, Tanja

AU - Kanerva, Anna

AU - Hemminki, Akseli

PY - 2017

Y1 - 2017

KW - CD40 ligand

KW - dendritic cells

KW - oncolytic adenovirus

KW - T-cells

KW - tumor microenvironment

KW - PROTECTIVE ANTITUMOR IMMUNITY

KW - VIVO GENE-TRANSFER

KW - CANCER-PATIENTS

KW - PROSTATE-CANCER

KW - BREAST-CANCER

KW - REPLICATING ADENOVIRUS

KW - CARCINOMA-CELLS

KW - SOLID TUMORS

KW - T-CELLS

KW - LIGAND

KW - 3111 Biomedicine

KW - 3122 Cancers

U2 - 10.1080/2162402X.2016.1265717

DO - 10.1080/2162402X.2016.1265717

M3 - Article

VL - 6

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 2

M1 - 1265717

ER -